• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Cardiovasc Imaging . Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study

tetano

Editor, Senior Moderator
Int J Cardiovasc Imaging


. 2020 Sep 9.
doi: 10.1007/s10554-020-02010-4. Online ahead of print.
Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study


Olivier Lairez[SUP] 1 2 3 4 5 [/SUP], Virginie Blanchard[SUP] 6 7 8 9 [/SUP], Val?rie Houard[SUP] 6 7 [/SUP], Fanny Vardon-Bounes[SUP] 10 [/SUP], Maeva Lemasle[SUP] 6 7 [/SUP], Eve Cariou[SUP] 6 7 [/SUP], Yoan Lavie-Badie[SUP] 6 7 8 [/SUP], St?phanie Ruiz[SUP] 10 [/SUP], St?phanie Cazalbou[SUP] 6 7 [/SUP], Cl?ment Delmas[SUP] 6 [/SUP], Bernard Georges[SUP] 10 [/SUP], Michel Galinier[SUP] 6 7 9 [/SUP], Didier Carri?[SUP] 6 7 9 [/SUP], Jean-Marie Conil[SUP] 10 [/SUP], Vincent Minville[SUP] 9 10 [/SUP]



Affiliations

Abstract

Biological cardiac injury related to the Severe Acute Respiratory Syndrome Coronavirus-2 infection has been associated with excess mortality. However, its functional impact remains unknown. The aim of our study was to explore the impact of biological cardiac injury on myocardial functions in patients with COVID-19. 31 patients with confirmed COVID-19 (CoV+) and 16 controls (CoV-) were prospectively included in this observational study. Demographic data, laboratory findings, comorbidities, treatments and myocardial function assessed by transthoracic echocardiography were collected and analysed in CoV+ with (TnT+) and without (TnT-) elevation of troponin T levels and compared with CoV-. Among CoV+, 13 (42%) exhibited myocardial injury. CoV+/TnT + patients were older, had lower diastolic arterial pressure and were more likely to have hypertension and chronic renal failure compared with CoV+/TnT-. The control group was comparable except for an absence of biological inflammatory syndrome. Left ventricular ejection fraction and global longitudinal strain were not different among the three groups. There was a trend of decreased myocardial work and increased peak systolic tricuspid annular velocity between the CoV- and CoV + patients, which became significant when comparing CoV- and CoV+/TnT+ (2167 ? 359 vs. 1774 ? 521%/mmHg, P = 0.047 and 14 ? 3 vs. 16 ? 3 cm/s, P = 0.037, respectively). There was a decrease of global work efficiency from CoV- (96 ? 2%) to CoV+/TnT- (94 ? 4%) and then CoV+/TnT+ (93 ? 3%, P = 0.042). In conclusion, biological myocardial injury in COVID 19 has low functional impact on left ventricular systolic function.

Keywords: COVID-19; Myocardial work.; SARS-CoV-2; Speckle tracking echocardiography; Strain.
 
Back
Top Bottom